With Brexit looming on the horizon, not enough has been…
Blockchain and Artificial Intelligence: Personalized Medicine
Blockchain and token rewards will liberate medical data and unlock data silos. What was kept private previously now can be tracked.
Data is the new oil and AI are the new engines of business. Therefore, the opening and incentivizing of data sharing will have synergistic effects for the healthcare industry as AI based insights thrive from the availability of high-quality big data.
In PharmaTrace ecosystem, prescribers will leverage a “medi-bot” to quickly support diagnosis and tailor treatment regiment with pre-trained models via AI.
These solutions will thrive on aggregated data from symptoms, historical and environmental events which are opened up for use by blockchain token-based rewards for data sharing.
However, this will only be possible if we align the deployment of blockchain as a data and ecosystem backbone, with compliance regulations such as GDPR.
Patients benefit in terms of quality and efficacy of treatment, saving time and lives.
Physicians can focus more on patients’ needs and adopt cutting edge therapies on the market.
Payers will benefit with physicians’ treatment (Tx) success stories, and be in the enviable position of rewarding higher per Tx performance while saving costs, allowing reinvestment for more acute matters.
Pharmaceutical companies will have more accessibility to prescribers, which will allow them to present more targeted innovations, a deeper knowledge of market conditions to access reimbursement schemes with national payers, and the ability to plan more pro-actively.